The emerging role of botulinum toxin in the treatment of temporomandibular disorders
- 18 April 2007
- journal article
- review article
- Published by Wiley in Oral Diseases
- Vol. 13 (3), 253-260
- https://doi.org/10.1111/j.1601-0825.2007.01352.x
Abstract
The objective of this review was to discuss the emerging role of botulinum toxin in the treatment of temporomandibular disorders (TMD), to review the current literature, recent clinical trials, as well as preliminary data from our own clinical study, and to formulate an algorithm for the work-up and treatment of TMD.This publication has 40 references indexed in Scilit:
- Review of a Proposed Mechanism for the Antinociceptive Action of Botulinum Toxin Type ANeuroToxicology, 2005
- Two TTX-resistant Na+ currents in mouse colonic dorsal root ganglia neurons and their role in colitis-induced hyperexcitabilityAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2004
- Regulation of Calcitonin Gene‐Related Peptide Secretion From Trigeminal Nerve Cells by Botulinum Toxin Type A: Implications for Migraine TherapyHeadache: The Journal of Head and Face Pain, 2004
- Botulinum Toxin: Basic Science and Clinical Uses in OtolaryngologyThe Laryngoscope, 2001
- Temporomandibular and Cervical Spine DisordersSpine, 1996
- Botulinum toxin in the treatment of myofascial pain syndromePain, 1994
- Prevalence in the Dutch Adult Population and a Meta-analysis of Signs and Symptoms of Temporomandibular DisorderJournal of Dental Research, 1993
- Epidemiology of Signs and Symptoms in Temporomandibular Disorders: Clinical Signs in Cases and ControlsThe Journal of the American Dental Association, 1990
- Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasmMovement Disorders, 1987
- Interaction of 125I-labeled botulinum neurotoxins with nerve terminals. I. Ultrastructural autoradiographic localization and quantitation of distinct membrane acceptors for types A and B on motor nerves.The Journal of cell biology, 1986